Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Jw Cayman Therapeutics Co Ltd
2126Current price
1.36 HKD
+0.09 HKD (+7.09%)
Last closed
1.27 HKD
Company
www.jwtherapeutics.com
ISIN
KYG5210T1040
Sector
Healthcare
Industry
Biotechnology
Exchange
Hong Kong Stock Exchange
Capitalization
547 080 237 HKD
Yield for 12 month
-37.61 %
1Y
3Y
5Y
10Y
15Y
2126
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People's Republic of China. It offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China. Address: Building B, Shanghai, China
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
23.23 HKDP/E ratio
–Dividend Yield
–Current Year
+173 896 148 HKD
Last Year
+145 735 650 HKD
Current Quarter
+87 760 263 HKD
Last Quarter
–
Current Year
+88 239 375 HKD
Last Year
+58 769 571 HKD
Current Quarter
+44 823 346 HKD
Last Quarter
–
Key Figures 2126
1 year
3 years
5 years
10 years
EBITDA
-427 363 185 HKD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.55 %
PEG Ratio
–
Return On Equity TTM
-34.67 %
Wall Street Target Price
23.23 HKD
Revenue TTM
172 970 945 HKD
Book Value
3.59 HKD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-1.1 %
Dividend Yield
–
Gross Profit TTM
58 769 569 HKD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 2126
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2126
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 2126
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.1331
Price Sales TTM
3.1628
Enterprise Value EBITDA
0.1195
Price Book MRQ
0.2888
Financials 2126
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2126
For 52 weeks
1.23 HKD
3.49 HKD
50 Day MA
1.64 HKD
Shares Short Prior Month
–
200 Day MA
2.04 HKD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart